Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dalia Lezzar"'
Publikováno v:
Biosensors, Vol 7, Iss 3, p 39 (2017)
Sickle cell anemia (SCA) is a genetic blood disorder that is particularly lethal in early childhood. Universal newborn screening programs and subsequent early treatment are known to drastically reduce under-five SCA mortality. However, in resource-li
Externí odkaz:
https://doaj.org/article/59d2a39fb50843e18976d1a2bf778b87
Autor:
Dalia Lezzar, Madeleine Lu, Riley C. Reddington, Celeste K. Kanne, Sergey S. Shevkoplyas, Vivien A. Sheehan
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Frontiers in Physiology
Biomarker development is a key clinical research need in sickle cell disease (SCD). Hemorheological parameters are excellent candidates as abnormal red blood cell (RBC) rheology plays a critical role in SCD pathophysiology. Here we describe a microfl
Publikováno v:
American Journal of Hematology. 93:E389-E391
Publikováno v:
Journal of Blood Medicine
Millions of blood components including red blood cells, platelets, and granulocytes are transfused each year in the United States. The transfusion of these blood products may be associated with adverse clinical outcomes in some patients due to residu
Publikováno v:
American Journal of Hematology. 90:478-482
Quantification of sickle hemoglobin (HbS) in patients with sickle cell disease (SCD) undergoing hydroxyurea or chronic transfusion therapy is essential to monitoring the effectiveness of these therapies. The clinical monitoring of %HbS using conventi
Publikováno v:
Biosensors; Volume 7; Issue 3; Pages: 39
Biosensors
Biosensors, Vol 7, Iss 3, p 39 (2017)
Biosensors
Biosensors, Vol 7, Iss 3, p 39 (2017)
Sickle cell anemia (SCA) is a genetic blood disorder that is particularly lethal in early childhood. Universal newborn screening programs and subsequent early treatment are known to drastically reduce under-five SCA mortality. However, in resource-li